alexa Magnetic Mirtazapine Loaded Poly(propylene glycol)bis(2aminopropylether) (PPG-NH2, MW_2000) Nanocarriers for Controlled Drug Release | OMICS International | Abstract
ISSN: 2169-0022

Journal of Material Sciences & Engineering
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Magnetic Mirtazapine Loaded Poly(propylene glycol)bis(2aminopropylether) (PPG-NH2, MW_2000) Nanocarriers for Controlled Drug Release

Jibowu T*, Rohani S and Ragab D

University of Western Ontario, London

*Corresponding Author:
Jibowu T
University of Western Ontario, London
Tel: 6475188496
E-mail: [email protected]

Received date: May 13, 2016; Accepted date: May 31, 2016; Published date: June 09, 2016

Citation: Jibowu T, Rohani S, Ragab D (2016) Magnetic Mirtazapine Loaded Poly (propylene glycol) bis(2aminopropylether) (PPG-NH2, MW_2000) Nanocarriers for Controlled Drug Release. J Material Sci Eng 5: 259. doi:10.4172/2169- 0022.1000259

Copyright: © 2016 Jibowu T, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Mirtazapine is an antidepressant that was introduced in 1996 for the treatment of moderate and severe depression. Mirtazapine is the only tetracyclic antidepressant that is approved by the Food and Drug Administration to treat depression. Mirtazapine is devoid of most side effects but has antihistamine side effects of drowsiness and weight gain. Its bioavailability is only fifty percent. The low bioavailability and side effects can be improved by altering the pharmokinetic profile of the drug by controlling the release of the drug. The slow release of the drug will reduce the harmful affect it has on the cells decreasing the side effects, as well as the loading of the drug in the nanocarrier will allow for a longer residence time in the body before it is removed by the gastrointestinal tract. In this research paper the pharmokinetic profile of Mirtazapine will be altered by surrounding the drug with a biodegradable polymer called poly(propylene glycol) bis(2-aminopropylether) (PPG-NH2, MW _ 2000) chains. This profile will be done at different polymer concentrations, drug concentrations and solubilizer concentration to see how this will affect the release of the drug. In this research project it was found that using a lower concentration of poly(propylene glycol) bis (2-aminopropylether) (PPG-NH2, MW_2000) chains of 0.5 g/mL led to a slower release in comparison to the other polymer concentrations with an encapsulation of 10 mg of Mirtazapine. When the drug weight was increased but the polymer concentration stayed the same (0.95 g/mL) the release rate increased with drug concentration. Also when the stabilizer concentration was increased, but the polymer concentration and drug concentration remained the same (0.95 g/mL and 10 mg respectively) the release rate increased. Therefore in order to allow for a slower release rate one should use the lower polymer concentration of 0.95 g/mL, with the lower concentration of stabilizer. This will allow for a slower release of the drug Mirtazapine which will lower the side effects and increase the bioavailability percentage.

Keywords

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version